Keyphrases
Visual Acuity
87%
Pars Plana Vitrectomy
54%
Endophthalmitis
48%
Diabetic Retinopathy
40%
Anti-VEGF Therapy
39%
Retinal Detachment
36%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
34%
Acute Onset
30%
Age-related Macular Degeneration
30%
Re-engagement
24%
Risk Factors
24%
Full-thickness Macular Hole
24%
Risk Prognosis
24%
Subretinal Space
24%
Clinical Features
24%
Patient Decision Aid
24%
Retinal pigment Epithelial Tear
24%
Photoreceptor
24%
Suprachoroidal Space
24%
Lamellar Macular Hole
24%
Acute Macular Neuroretinopathy
24%
Spontaneous Transformation
24%
Practice Preferences
24%
Ischemic Index
24%
Anterior Segment Imaging
24%
Subretinal Delivery
24%
Multiple Evanescent White Dot Syndrome (MEWDS)
24%
Surgical Outcomes
24%
Ultra-high Speed
24%
Surgical Aortic Valve Replacement
24%
Swept-source Optical Coherence Tomography (SS-OCT)
24%
Valve Choice
24%
Autofluorescence
24%
Risk Treatment
24%
Telehealth
24%
Ophthalmological
24%
Intravitreal Pharmacotherapies
24%
Retinal Vascular Disease
24%
Economic Viability
24%
Outcome Preferences
24%
Ultra-widefield Fluorescein Angiography
24%
Pneumatic Retinopexy
24%
Beta-propeller Protein-associated Neurodegeneration
24%
Fundus Autofluorescence
24%
Wide-field
24%
Physician Extenders
24%
Aphelion
24%
Treatment Trials
24%
Anti-vascular Endothelial Growth Factor Therapy
24%
Intravitreal Anti-vascular Endothelial Growth Factor Injection
24%
Medicine and Dentistry
Visual Acuity
100%
Vasculotropin
66%
Diabetic Retinopathy
64%
Branch Retinal Vein Occlusion
48%
Pars Plana Vitrectomy
48%
Endophthalmitis
48%
Retinal Detachment
33%
Optical Coherence Tomography
31%
Drug Therapy
31%
Cataract
27%
Multimodal Imaging
27%
Neurodegeneration
24%
Iris
24%
Photoreceptor
24%
Fluorescein Angiography
24%
Macular Hole
24%
Multiple Evanescent White Dot Syndrome
24%
Retina Neovascularization
24%
Melanocytic Proliferation
24%
Telehealth
24%
Image Quality
24%
Clinical Feature
24%
Autofluorescence
24%
Vascular Disease
24%
Palucorcel
24%
Retinopexy
24%
Retina Tear
24%
Central Retinal Vein Occlusion
24%
Intravitreal Administration
24%
Remote Sensing
24%
Contrast Sensitivity
24%
Vision
24%
Maculopathy
24%
Ultrasound Biomicroscopy
18%
Disease
15%
Health Care Cost
14%
Age Related Macular Degeneration
12%
Fluorescein
12%
Ciliary Body
12%
Subretinal Fluid
12%
Diagnosis
12%
Laceration
12%
Retrobulbar Hemorrhage
12%
Pantothenate Kinase-Associated Neurodegeneration
12%
Brainstem
12%
Eye Surgery
12%
Retinal Disease
12%
English (Language)
12%
Retrobulbar Drug Administration
12%
Scleral Buckle
11%